![Wayne Kanack](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Wayne Kanack worked as a Controller at Neos Therapeutics, Inc. from 2005 to 2007.
He received his undergraduate degree from The University of Texas at Austin in 1983.
Former positions of Wayne Kanack
Companies | Position | End |
---|---|---|
NEOS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2007-02-28 |
Training of Wayne Kanack
The University of Texas at Austin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Neos Therapeutics, Inc.
![]() Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
- Stock Market
- Insiders
- Wayne Kanack